SUN PHARMACEUTICAL INDUSTRIES INC 2022-12-28 Health serious FDA
Health · FDA · Recall #FDA-D-0085-2023
Oxcarbazepine Tablets 600mg, packaged in a) 100- count bottles (NDC 62756-185-88), b)… Recall
Issued December 28, 2022 · SUN PHARMACEUTICAL INDUSTRIES INC
In December 2022, SUN PHARMACEUTICAL INDUSTRIES INC recalled the Oxcarbazepine Tablets 600mg, packaged in a) 100- count bottles (NDC 62756-185-88), b)…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Presence of foreign substance
What you should do
- 1 Stop using Oxcarbazepine Tablets 600mg, packaged in a) 100- count bottles (NDC 62756-185-88), b)… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact SUN PHARMACEUTICAL INDUSTRIES INC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Health
- Recall date
- December 28, 2022
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-0085-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- SUN PHARMACEUTICAL INDUSTRIES INC has 34 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.